Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! Registry.
Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, Kheir WJ, Kok G, Vujosevic S, O'Toole L, Mangelschots E, Jaross N, Ceklic L, Daien V, Viola F, Squirrell D, Lavid FJ, Creuzot-Garcher C, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group. Mehta H, et al. Among authors: daien v. Ophthalmol Retina. 2024 Apr 16:S2468-6530(24)00182-9. doi: 10.1016/j.oret.2024.04.008. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38615818 Free article.
Nanotopography by chromatic confocal microscopy of the endothelium in Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy and healthy corneas.
Vaitinadapoulé H, Poinard S, He Z, Pascale-Hamri A, Thomas J, Gain P, Thuret JY, Mascarelli F, Thuret G; French Fuchs Study Group (FFSG). Vaitinadapoulé H, et al. Br J Ophthalmol. 2023 Sep 15:bjo-2023-323297. doi: 10.1136/bjo-2023-323297. Online ahead of print. Br J Ophthalmol. 2023. PMID: 37714683
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
Debourdeau E, Medard R, Chamard C, Nguyen V, Gabrielle PH, Creuzot-Garcher C, Allieu S, Gillies MC, Barthelmes D, Daien V; Fight Retinal Blindness! Study Group. Debourdeau E, et al. Among authors: daien v. Ophthalmol Ther. 2023 Oct;12(5):2657-2670. doi: 10.1007/s40123-023-00758-1. Epub 2023 Jul 28. Ophthalmol Ther. 2023. PMID: 37505396 Free PMC article.
Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management.
Thorel D, Ingen-Housz-Oro S, Benaïm D, Daien V, Gabison E, Saunier V, Béral L, Touboul D, Brémond-Gignac D, Robert M, Vasseur R, Royer G, Dereure O, Milpied B, Bernier C, Welfringer-Morin A, Bodemer C, Cordel N, Tauber M, Burillon C, Servant M, Couret C, Vabres B, Tétart F, Cassagne M, Kuoch MA, Muraine M, Delcampe A, Gueudry J. Thorel D, et al. Among authors: daien v. Orphanet J Rare Dis. 2023 Mar 11;18(1):51. doi: 10.1186/s13023-023-02616-6. Orphanet J Rare Dis. 2023. PMID: 36906580 Free PMC article. Review.
Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans.
Mauschitz MM, Verzijden T, Schuster AK, Elbaz H, Pfeiffer N, Khawaja A, Luben RN, Foster PJ, Rauscher FG, Wirkner K, Kirsten T, Jonas JB, Bikbov MM, Hogg R, Peto T, Cougnard-Grégoire A, Bertelsen G, Erke MG, Topouzis F, Giannoulis DA, Brandl C, Heid IM, Creuzot-Garcher CP, Gabrielle PH, Hense HW, Pauleikhoff D, Barreto P, Coimbra R, Piermarocchi S, Daien V, Holz FG, Delcourt C, Finger RP; European Eye Epidemiology (E3) Consortium. Mauschitz MM, et al. Among authors: daien v. Br J Ophthalmol. 2023 Nov 22;107(12):1880-1886. doi: 10.1136/bjo-2022-321985. Br J Ophthalmol. 2023. PMID: 36344262
133 results